Meag Munich Ergo’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,000
Closed -$183K 221
2020
Q2
$183K Hold
2,000
0.03% 189
2020
Q1
$180K Sell
2,000
-18,820
-90% -$2M 0.04% 168
2019
Q4
$2.35M Sell
20,820
-67,811
-77% -$7.44M 0.25% 103
2019
Q3
$9.47M Buy
88,631
+37,629
+74% +$3.93M 0.49% 50
2019
Q2
$4.98M Hold
51,002
0.39% 61
2019
Q1
$4.58M Buy
+51,002
New +$4.56M 0.38% 66
2018
Q4
Sell
-92,208
Closed -$8.96M 380
2018
Q3
$8.96M Buy
92,208
+5,842
+7% +$540K 0.53% 54
2018
Q2
$7.52M Sell
86,366
-44,711
-34% -$3.73M 0.47% 62
2018
Q1
$10.2M Buy
131,077
+66,204
+102% +$5.46M 0.42% 67
2017
Q4
$5.31M Buy
+64,873
New +$5.2M 0.2% 137
2017
Q3
Sell
-203,836
Closed -$18M 308
2017
Q2
$18M Sell
203,836
-270,059
-57% -$22.8M 0.8% 30
2017
Q1
$27.7M Buy
473,895
+300,633
+174% +$23.5M 1.09% 13
2016
Q4
$12.5M Buy
173,262
+28,126
+19% +$2.21M 0.58% 46
2016
Q3
$12.4M Buy
145,136
+141,136
+3,528% +$12.3M 0.61% 53
2016
Q2
$347K Sell
4,000
-42,096
-91% -$3.4M 0.03% 150
2016
Q1
$3.47M Sell
46,096
-92
-0.2% -$6.93K 0.18% 138
2015
Q4
$3.6M Buy
46,188
+42,188
+1,055% +$3.18M 0.18% 144
2015
Q3
$239K Sell
4,000
-168,065
-98% -$12.4M 0.01% 205
2015
Q2
$12.8M Sell
172,065
-51,039
-23% -$3.9M 0.66% 52
2015
Q1
$17.4M Buy
223,104
+94,464
+73% +$7.16M 0.83% 34
2014
Q4
$9.41M Sell
128,640
-17
-0% -$1.18K 0.43% 83
2014
Q3
$7.98M Sell
128,657
-100,243
-44% -$6.37M 0.37% 91
2014
Q2
$14.6M Buy
228,900
+129,757
+131% +$7.88M 0.64% 50
2014
Q1
$6.09M Buy
99,143
+1,527
+2% +$88.9K 0.45% 78
2013
Q4
$5.59M Sell
97,616
-112,720
-54% -$6.39M 0.33% 100
2013
Q3
$11.3M Buy
210,336
+157,402
+297% +$8.47M 0.79% 47
2013
Q2
$2.75M Buy
+52,934
New +$2.62M 0.21% 118

Other funds holding MDT

Meag Munich Ergo's MDT Position: Q3 2020 in Review

Meag Munich Ergo sold out of Medtronic (MDT) in Q3 2020, closing a stake of 2,000 shares — an estimated $183K sold.

Meag Munich Ergo first reported a position in MDT in Q2 2013 and held it in 27 quarters. The position peaked at $27.7M in Q1 2017. 1,810 funds tracked by Wall St. Rank hold MDT as of Q3 2020.

  • Meag Munich Ergo reported no remaining Medtronic position as of Q3 2020 after selling out during the quarter.
  • Meag Munich Ergo sold 2,000 Medtronic shares in Q3 2020, an estimated $183K.
  • Meag Munich Ergo first reported a position in Medtronic in Q2 2013 and held it in 27 quarters.
  • Meag Munich Ergo's Medtronic position peaked at $27.7M in Q1 2017.
  • 1,810 funds tracked by Wall St. Rank held Medtronic as of Q3 2020.

Based on Meag Munich Ergo's 13F filing for Q3 2020, filed 20 Oct 2020.